|
Aug 9
|
Xenon Pharmaceuticals (XENE) Reports Q2 Loss, Misses Revenue Estimates
|
|
Aug 9
|
Xenon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
|
|
Aug 9
|
Companies Like Xenon Pharmaceuticals (NASDAQ:XENE) Are In A Position To Invest In Growth
|
|
Aug 8
|
Xenon Pharmaceuticals Expands Leadership on its Board of Directors with Appointments of Gillian M. Cannon and Justin Gover
|